1. Rapamycin, an Immunosuppressant and mTORC1 Inhibitor, Triples the Antidepressant Response Rate of Ketamine at 2 Weeks Following Treatment: a Double-blind, Placebo-controlled, Cross-over, Randomized Clinical Trial;Abdallah,2018
2. Ketamine;Aronson,2016
3. Parsing the heterogeneity of depression: an exploratory factor analysis across commonly used depression rating scales;Ballard;J. Affect. Disord.,2018
4. Antidepressant effects of ketamine in depressed patients;Berman;Biol. Psychiatr.,2000
5. Clinical Review;Center for Drug Evaluation and Research,2019